A Pharmacokinetic Study of KW-6356 in Subjects With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function
Latest Information Update: 24 Jul 2023
At a glance
- Drugs Sipagladenant (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Kyowa Kirin
Most Recent Events
- 24 Apr 2020 Status changed from recruiting to completed.
- 10 Dec 2019 New trial record